Desouky, S., Hussein, A., Montasser, M., Mohamed, M., Abdel Gawad Hozaifa, W. (2024). RECENT UPDATES IN THE ROLE OF MULTI-DETECTOR COMPUTED TOMOGRAPHY IN EVALUATION OF PANCREATIC CANCER RESECTABILITY. test, 6(3), 37-38. doi: 10.21608/alexpo.2024.309902.1908
Salaheldin Desouky; Alaa Hussein; Moataz Montasser; Mohamed Masoud Radwan Mohamed; Walaa Abdou Abdel Gawad Hozaifa. "RECENT UPDATES IN THE ROLE OF MULTI-DETECTOR COMPUTED TOMOGRAPHY IN EVALUATION OF PANCREATIC CANCER RESECTABILITY". test, 6, 3, 2024, 37-38. doi: 10.21608/alexpo.2024.309902.1908
Desouky, S., Hussein, A., Montasser, M., Mohamed, M., Abdel Gawad Hozaifa, W. (2024). 'RECENT UPDATES IN THE ROLE OF MULTI-DETECTOR COMPUTED TOMOGRAPHY IN EVALUATION OF PANCREATIC CANCER RESECTABILITY', test, 6(3), pp. 37-38. doi: 10.21608/alexpo.2024.309902.1908
Desouky, S., Hussein, A., Montasser, M., Mohamed, M., Abdel Gawad Hozaifa, W. RECENT UPDATES IN THE ROLE OF MULTI-DETECTOR COMPUTED TOMOGRAPHY IN EVALUATION OF PANCREATIC CANCER RESECTABILITY. test, 2024; 6(3): 37-38. doi: 10.21608/alexpo.2024.309902.1908

RECENT UPDATES IN THE ROLE OF MULTI-DETECTOR COMPUTED TOMOGRAPHY IN EVALUATION OF PANCREATIC CANCER RESECTABILITY

ALEXMED ePosters
Article 1, Volume 6, Issue 3, July 2024, Pages 37-38
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.309902.1908
Authors
Salaheldin Desouky1; Alaa Hussein2; Moataz Montasser3; Mohamed Masoud Radwan Mohamed4; Walaa Abdou Abdel Gawad Hozaifa* 5
1Department of Radiodiagnosis, Faculty of medicine, Alexandria university, Alexandria, Egypt
2professor of hepato-biliary and pancreatic surgery, faculty of Medicine, Alexandria university.
3Assisstant professor of radiodiagnosis and intervention, faculty of Medicine, Alexandria university
4Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Alexandria University
5Department of radiodiagnosis and intervention, faculty of Medicine, Alexandria university.
Abstract
INTRODUCTION
Pancreatic cancer has one of the worst prognosis among all malignancies and is projected to become the second leading cause of cancer-related deaths in certain regions. It is the fourth leading cause of cancer-related deaths worldwide.
pancreatic cancer has a low 5-year survival rate of 2% to 9%, which remains consistent across both high-income and low- to middle-income countries. This survival rate also varies by location and country, but it never exceeds 10%.
Adenocarcinoma is the most common type of pancreatic cancer . The name 'silent killer' has been given to this cancer because it progresses silently, has late clinical signs, and grows rapidly.
.
AIM OF THE WORK
The main goal of our study was to assess the recent updates in the role of MDCT in prediction of resectability of pancreatic cancer
SUBJECTS AND METHODS
Target population:
The study was carried out on 42 patients with approved manifestations of cancer pancreas who admitted to Alexandria main university hospital and Gamal Abdel Naser insurance hospital for diagnosis and management.
Before CT imaging, all individuals were subjected to:
I. Informed written consent.
II. Full history and clinical examination.
III. General and abdominal examinations by the referral clinician.
IV. Laboratory investigations.
V. Imaging techniques:
Keywords
EVALUATION; OF; PANCREATIC; CANCER; RESECTABILITY
Supplementary Files
Statistics
Article View: 41